Your browser doesn't support javascript.
loading
Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.
Chapel, David B; Schulte, Jefree J; Absenger, Gudrun; Attanoos, Richard; Brcic, Luka; Butnor, Kelly J; Chirieac, Lucian; Churg, Andrew; Galateau-Sallé, Françoise; Hiroshima, Kenzo; Hung, Yin P; Kindler, Hedy; Krausz, Thomas; Marchevsky, Alberto; Mino-Kenudson, Mari; Mueller, Jeffrey; Nabeshima, Kazuki; Turaga, Kirin; Walts, Ann E; Husain, Aliya N.
Afiliação
  • Chapel DB; Department of Pathology, University of Chicago, Chicago, IL, USA. dchapel@bwh.harvard.edu.
  • Schulte JJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. dchapel@bwh.harvard.edu.
  • Absenger G; Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Attanoos R; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.
  • Brcic L; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.
  • Butnor KJ; Department of Cellular Pathology, University Hospital of Wales and School of Medicine, Cardiff University, Cardiff, Wales, UK.
  • Chirieac L; Diagnostic and Research Institute of Pathology, Medical University of Graz, Neue Stiftingtalstrasse 6, 8010, Graz, Austria.
  • Churg A; Department of Pathology, University of Vermont Medical Center, Burlington, VT, USA.
  • Galateau-Sallé F; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Hiroshima K; Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
  • Hung YP; Centre National Référent MESOPATH, Centre Léon Bérard, Lyon, France.
  • Kindler H; Department of Biochemistry and Genetics, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Krausz T; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Marchevsky A; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Mino-Kenudson M; Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Mueller J; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Nabeshima K; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Turaga K; Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Walts AE; Department of Pathology, Fukuoka University School of Medicine and Hospital, Jonan-ku, Fukuoka, Japan.
  • Husain AN; Department of Surgery, University of Chicago, Chicago, IL, USA.
Mod Pathol ; 34(2): 380-395, 2021 02.
Article em En | MEDLINE | ID: mdl-33060816
ABSTRACT
Malignant peritoneal mesothelioma historically carried a grim prognosis, but outcomes have improved substantially in recent decades. The prognostic significance of clinical, morphologic, and immunophenotypic features remains ill-defined. This multi-institutional cohort comprises 225 malignant peritoneal mesotheliomas, which were assessed for 21 clinical, morphologic, and immunohistochemical parameters. For epithelioid mesotheliomas, combining nuclear pleomorphism and mitotic index yielded a composite nuclear grade, using a previously standardized grading system. Correlation of clinical, morphologic, and immunohistochemical parameters with overall and disease-free survival was examined by univariate and multivariate analyses. On univariate analysis, longer overall survival was significantly associated with diagnosis after 2000 (P = 0.0001), age <60 years (P = 0.0001), ECOG performance status 0 or 1 (P = 0.01), absence of radiographic lymph-node metastasis (P = 0.04), cytoreduction surgery (P < 0.0001), hyperthermic intraperitoneal chemotherapy (P = 0.0001), peritoneal carcinomatosis index <27 (P = 0.01), absence of necrosis (P = 0.007), and epithelioid histotype (P < 0.0001). Among epithelioid malignant mesotheliomas only, longer overall survival was further associated with female sex (P = 0.03), tubulopapillary architecture (P = 0.005), low nuclear pleomorphism (P < 0.0001), low mitotic index (P = 0.0007), and low composite nuclear grade (P < 0.0001). On multivariate analyses, the low composite nuclear grade was independently associated with longer overall and disease-free survival (P < 0.0001). Our data further clarify the interactions of clinical and pathologic features in peritoneal mesothelioma prognosis and validate the prognostic significance of a standardized nuclear-grading system in epithelioid malignant mesothelioma of the peritoneum.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Gradação de Tumores / Mesotelioma Maligno Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Gradação de Tumores / Mesotelioma Maligno Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos